• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[母亲服用阿维A酯治疗毛囊角化病后出现胚胎畸形]

[Embryonal malformation following etretinate therapy of Darier's disease in the mother].

作者信息

Kietzmann H, Schwarze I, Grote W, Ravens U, Jänig U, Harms D

出版信息

Dtsch Med Wochenschr. 1986 Jan 10;111(2):60-2. doi: 10.1055/s-2008-1068402.

DOI:10.1055/s-2008-1068402
PMID:3940838
Abstract

A 22-year-old woman suffering from dyskeratosis follicularis Darier became pregnant 4 months after the last dose of etretinate (Tigason). The pregnancy was terminated in the 10th week because of teratogenic risk. The pathological examination of the fetus revealed severe malformation of the left leg with aplasia of tibia and fibula, as well as hypoplasia of the left femur. This observation emphasises the necessity of effective contraception even after discontinuation of etretinate therapy.

摘要

一名患有毛囊角化病(达里埃病)的22岁女性在最后一剂阿维A酯(银屑灵)服用4个月后怀孕。由于存在致畸风险,妊娠在第10周时终止。对胎儿的病理检查显示左腿严重畸形,胫骨和腓骨发育不全,以及左股骨发育不良。这一观察结果强调了即使在阿维A酯治疗停药后仍需采取有效避孕措施的必要性。

相似文献

1
[Embryonal malformation following etretinate therapy of Darier's disease in the mother].[母亲服用阿维A酯治疗毛囊角化病后出现胚胎畸形]
Dtsch Med Wochenschr. 1986 Jan 10;111(2):60-2. doi: 10.1055/s-2008-1068402.
2
[Teratogenic effects of etretinate in humans].[维甲酸对人类的致畸作用]
Dtsch Med Wochenschr. 1984 Sep 28;109(39):1476-80. doi: 10.1055/s-2008-1069397.
3
Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).用维甲酸衍生物Ro 10-9359(替加松)治疗毛囊角化病(达里埃病)
Dermatologica. 1981;163(2):164-8.
4
Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.母亲阿维A酯治疗终止4个月后受孕胎儿的畸形。
Lancet. 1985 Jun 1;1(8440):1276. doi: 10.1016/s0140-6736(85)92344-x.
5
Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
N Z Med J. 1981 Aug 12;94(689):99-100.
6
The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
Br J Dermatol. 1981 Jun;104(6):675-9. doi: 10.1111/j.1365-2133.1981.tb00754.x.
7
Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier's disease.
Acta Derm Venereol. 1982;62(3):267-8.
8
[Treatment of dyskeratosis follicularis (Darier's disease) with aromatic retinoid].芳香维甲酸治疗毛囊角化病(达里埃病)
Przegl Dermatol. 1987 Nov-Dec;74(6):443-8.
9
Etretinate embryotoxicity 7 months after discontinuation of treatment.
Am J Med Genet. 1990 Nov;37(3):437-8. doi: 10.1002/ajmg.1320370333.
10
[Dyskeratosis follicularis vegetans (Darier disease)--therapy with the aromatic retinoid RO 10-9359 (Tigason) in combination with systemic photochemotherapy (RePUVA)].
Dermatol Monatsschr. 1982 Aug;168(8):520-2.

引用本文的文献

1
The retinoids. A review of their clinical pharmacology and therapeutic use.维甲酸类药物。其临床药理学与治疗应用综述。
Drugs. 1987 Oct;34(4):459-503. doi: 10.2165/00003495-198734040-00003.
2
Species differences in pharmacokinetics and drug teratogenesis.药代动力学和药物致畸作用中的物种差异。
Environ Health Perspect. 1986 Dec;70:113-29. doi: 10.1289/ehp.8670113.